Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany

Population-based studies of SARS-CoV-2 seroprevalence are needed to understand levels of immunity and antibody dynamics. Here, the authors show that the seroprevalence in Bonn, Germany was low (<1%) following the first epidemic wave, and that neutralising antibodies waned within a few months.

Bibliographic Details
Main Authors: N. Ahmad Aziz, Victor M. Corman, Antje K. C. Echterhoff, Marcel A. Müller, Anja Richter, Antonio Schmandke, Marie Luisa Schmidt, Thomas H. Schmidt, Folgerdiena M. de Vries, Christian Drosten, Monique M. B. Breteler
Format: Article
Language:English
Published: Nature Portfolio 2021-04-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-021-22351-5

Internet

https://doi.org/10.1038/s41467-021-22351-5

Similar Items